XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2023 $ 1,516,387 $ 142 $ 387,210 $ (10,261) $ 22,865 $ 882,943 $ 233,488
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 12,665         5,581 7,084
Other comprehensive income (loss) 4,727       4,727    
Amounts reclassified from Accumulated other comprehensive income (loss) (4,181)       (4,181)    
Distributions to noncontrolling interests (44,910)           (44,910)
Stock awards issued to employees and directors, net of income tax (3,180)   (12,749) 9,569      
Dividends declared per common share (6,470)         (6,470)  
Restricted share award dividend equivalents 612   694 61   (143)  
Ending Balance at Mar. 31, 2024 1,475,650 142 375,155 (631) 23,411 881,911 195,662
Beginning Balance at Dec. 31, 2024 1,599,836 $ 142 385,609 (2,860) 12,585 970,710 233,650
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 5,331         284 5,047
Other comprehensive income (loss) (1,440)       (1,440)    
Amounts reclassified from Accumulated other comprehensive income (loss) (2,288)       (2,288)    
Stock awards issued to employees and directors, net of income tax (in shares)   1          
Stock awards issued to employees and directors, net of income tax 590   (3,454) 4,043      
Purchase of treasury shares (1,184)     (1,184)      
Dividends declared per common share (6,667)         (6,667)  
Restricted share award dividend equivalents 256   468 1   (213)  
Ending Balance at Mar. 31, 2025 $ 1,594,434 $ 143 $ 382,623 $ 0 $ 8,857 $ 964,114 $ 238,697